Ori Biotech nets $9.4 mln seed

London and Philadelphia-based Ori Biotech Ltd, a provider of cell and gene therapy manufacturing, has raised $9.4 million in seed funding.

London and Philadelphia-based Ori Biotech Ltd, a provider of cell and gene therapy manufacturing, has raised $9.4 million in seed funding. The investors included Amadeus Capital Partners, Delin Ventures and Kindred Capital.

Source: Press Release